Immunohistochemical staining of tumor sections from the GA-amide-treated transgenic mice revealed lower expression of the proliferation marker Ki67 (Supplementary Fig. 4a) and GSC marker CD133 (Supplementary Fig. 4b). Here, PROM1 is linked to neoplasm.